Abstract
Diabetic Nephropathy is the most common cause of end renal failure worldwide.
Microalbuminia is considered to be the first risk of Diabetic Nephropathy, which can be prevented and treated at early stage. Slight elevation of protein albumin level in the urine could be one of the earlier signs of diabetic nephropathy.
Microalbuminuria increases the risk of cardiovascular disease in diabetic and hypertension patients.
Microalbuminuria is more common in poorly controlled diabetic patients with high blood pressure, and a very clear risk factor for renal dysfunction. For incidence of Microalbuminuria where systolic blood pressure, plasma triglycerides and urinary albumin, antihypertensive drugs have been shown to reduce factors of Microalbuminuria and renal dysfunction.